Medicare AdvantageCoverageMedium impact
MA11.001l, Treatment of Varicose Veins of the Lower Extremities and Perforator Vein Incompetence
Independence Blue Cross·Vascular Surgery, General Surgery, Dermatology·Medical Policy
Effective date
Jan 1, 2026
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA11.001l for treatment of varicose veins of the lower extremities and perforator vein incompetence has been updated with new requirements effective January 1, 2026. This policy change affects billing and coverage criteria for varicose vein treatments under Medicare Advantage plans.
Action Required
Before January 1, 2026: Billing team must review the complete updated policy MA11.001l at the provided URL to understand new coverage criteria and billing requirements for varicose vein treatments. Update billing procedures and prior authorization workflows for Medicare Advantage patients requiring varicose vein procedures. Ensure providers are aware of any new documentation requirements.